This Medicines and Healthcare products Regulatory Agency (MHRA) guidance is for those who want to manufacture, import, distribute or supply unlicensed medicines for human use (also known as ‘specials’).
‘Specials’ are products which have been specially manufactured or imported for the treatment of an individual patient after being ordered by a:
- nurse independent prescriber
- pharmacist independent prescriber
- supplementary prescriber